Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Angioedema With C1 Esterase Inhibitor Deficiency”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02741596
What this trial is testing

Long-term Safety and Efficacy Study of DX-2930 (SHP643) to Prevent Acute Angioedema Attacks in Patients With Type I and Type II HAE

Who this might be right for
Hereditary Angioedema (HAE)
Shire 212
Large-scale testing (Phase 3)Active Not RecruitingNCT05453968
What this trial is testing

Berotralstat Treatment in Children With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaPediatric
BioCryst Pharmaceuticals 29
Testing effectiveness (Phase 2)Study completedNCT00261053
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Genetic Disorders
Pharming Technologies B.V. 14
Not applicableStudy completedNCT06408805
What this trial is testing

Autonomic Nervous System Profile in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Istituti Clinici Scientifici Maugeri SpA 60
Large-scale testing (Phase 3)Active Not RecruitingNCT06669754
What this trial is testing

Study of Oral Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With HAE

Who this might be right for
Hereditary Angioedema (HAE)
Pharvaris Netherlands B.V. 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT05691361
What this trial is testing

Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Who this might be right for
Hereditary Angioedema
ADARx Pharmaceuticals, Inc. 53
Large-scale testing (Phase 3)Study completedNCT05139810
What this trial is testing

OASIS-HAE: A Study to Evaluate the Safety and Efficacy of Donidalorsen (ISIS 721744 or IONIS-PKK-LRx) in Participants With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 91
Not applicableNot Yet RecruitingNCT05833620
What this trial is testing

Identification and Characterization of Genetic Variants in Hereditary Angioedema

Who this might be right for
Hereditary Angioedema With C1 Esterase Inhibitor Deficiency
Hospital Universitari Vall d'Hebron Research Institute 200
Testing effectiveness (Phase 2)Study completedNCT01984788
What this trial is testing

Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE

Who this might be right for
Hereditary Angioedema
BioCryst Pharmaceuticals 24
Not applicableStudy completedNCT06346899
What this trial is testing

Lanadelumab (Takhzyro) and Icatibant (Firazyr®) in Persons With HAE in China

Who this might be right for
Hereditary Angioedema (HAE)
Takeda 115
Testing effectiveness (Phase 2)Study completedNCT04307381
What this trial is testing

An Extension Study of Donidalorsen (IONIS-PKK-LRx) in Participants With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema
Ionis Pharmaceuticals, Inc. 20
Large-scale testing (Phase 3)Study completedNCT00262301
What this trial is testing

Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema

Who this might be right for
Hereditary AngioedemaAngioneurotic EdemaGenetic Disorders
Pharming Technologies B.V. 75
Testing effectiveness (Phase 2)Ended earlyNCT04414631
What this trial is testing

Conestat Alfa in the Prevention of Severe SARS-CoV-2 Infection in Hospitalized Patients With COVID-19

Who this might be right for
Coronavirus Infections
University Hospital, Basel, Switzerland 80
Testing effectiveness (Phase 2)Study completedNCT02247739
What this trial is testing

HAE Prophylaxis Study With Recombinant Human C1 Inhibitor

Who this might be right for
Hereditary Angioedema
Pharming Technologies B.V. 32
Testing effectiveness (Phase 2)Active Not RecruitingNCT06846398
What this trial is testing

In Adult Subjects With Hereditary Angioedema

Who this might be right for
Hereditary Angioedema (HAE)
Shanghai Argo Biopharmaceutical Co., Ltd. 25
Large-scale testing (Phase 3)Looking for participantsNCT06361537
What this trial is testing

Study of IV Human Plasma-derived C1 Esterase Inhibitor Concentrate in Patients With Congenital C1-INH Deficiency for Treatment and Pre-procedure Preventing of Acute Hereditary Angioedema Attacks

Who this might be right for
Acute Hereditary Angio Edema
Octapharma 124
Not applicableEnded earlyNCT02892682
What this trial is testing

The Role of the Coagulation Pathways in Recurrent Angioedema

Who this might be right for
Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency
University Hospital, Montpellier 96
Testing effectiveness (Phase 2)Study completedNCT01576523
What this trial is testing

Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route

Who this might be right for
Hereditary Angioedema Types I and II
CSL Behring 18
Not applicableApproved For MarketingNCT04428632
What this trial is testing

Oral Berotralstat Expanded Access Program

Who this might be right for
Hereditary AngioedemaHAEProphylaxis
BioCryst Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT05259917
What this trial is testing

A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema
KalVista Pharmaceuticals, Ltd. 136
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation